Share Price and Basic Stock Data
Last Updated: February 27, 2025, 2:43 pm
PEG Ratio | 0.44 |
---|
Competitors of GHCL Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
Caprolactam Chemicals Ltd | 22.5 Cr. | 48.9 | 65.0/43.0 | 11.6 | 0.00 % | 6.86 % | 3.67 % | 10.0 | |
Standard Industries Ltd | 129 Cr. | 19.9 | 39.0/17.5 | 138 | 20.1 | 5.28 % | 6.83 % | 6.28 % | 5.00 |
Gujarat Alkalies & Chemicals Ltd | 4,039 Cr. | 550 | 900/550 | 842 | 0.00 % | 3.83 % | 3.88 % | 10.0 | |
GHCL Ltd | 5,587 Cr. | 584 | 779/435 | 9.31 | 331 | 2.04 % | 20.6 % | 17.3 % | 10.0 |
Tata Chemicals Ltd | 20,456 Cr. | 803 | 1,350/802 | 42.0 | 871 | 1.83 % | 7.81 % | 2.32 % | 10.0 |
Industry Average | 6,271.80 Cr | 467.47 | 63.38 | 392.45 | 1.55% | 9.52% | 6.89% | 9.17 |
Quarterly Result
Metric | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 807 | 708 | 721 | 698 | 803 | 1,005 | 1,053 | 1,148 | 1,381 | 1,102 | 1,119 | 1,017 | 805 |
Expenses | 647 | 527 | 530 | 540 | 634 | 756 | 723 | 789 | 947 | 735 | 771 | 719 | 592 |
Operating Profit | 159 | 180 | 191 | 158 | 169 | 249 | 330 | 359 | 434 | 367 | 348 | 298 | 213 |
OPM % | 20% | 26% | 26% | 23% | 21% | 25% | 31% | 31% | 31% | 33% | 31% | 29% | 26% |
Other Income | 10 | 18 | 5 | 19 | 20 | 12 | 54 | 128 | 1 | 4 | -2 | 232 | 11 |
Interest | 24 | 16 | 16 | 15 | 15 | 15 | 15 | 10 | 11 | 10 | 10 | 8 | 7 |
Depreciation | 33 | 29 | 28 | 28 | 29 | 30 | 22 | 22 | 32 | 22 | 27 | 24 | 26 |
Profit before tax | 112 | 154 | 152 | 134 | 144 | 216 | 348 | 455 | 392 | 339 | 309 | 497 | 191 |
Tax % | 25% | 23% | 27% | 23% | 24% | 25% | 22% | 19% | 25% | 26% | 27% | 14% | 25% |
Net Profit | 84 | 118 | 111 | 103 | 110 | 163 | 272 | 369 | 293 | 252 | 227 | 426 | 143 |
EPS in Rs | 8.89 | 12.38 | 11.70 | 10.80 | 11.53 | 17.07 | 28.52 | 38.56 | 30.60 | 26.38 | 23.70 | 44.60 | 14.94 |
Last Updated: Unknown
Below is a detailed analysis of the quarterly data for GHCL Ltd based on the most recent figures (Sep 2023) and their trends compared to the previous period:
- For Sales, as of Sep 2023, the value is ₹805.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹1,017.00 Cr. (Jun 2023) to ₹805.00 Cr., marking a decrease of ₹212.00 Cr..
- For Expenses, as of Sep 2023, the value is ₹592.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from ₹719.00 Cr. (Jun 2023) to ₹592.00 Cr., marking a decrease of ₹127.00 Cr..
- For Operating Profit, as of Sep 2023, the value is ₹213.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹298.00 Cr. (Jun 2023) to ₹213.00 Cr., marking a decrease of ₹85.00 Cr..
- For OPM %, as of Sep 2023, the value is 26.00%. The value appears to be declining and may need further review. It has decreased from 29.00% (Jun 2023) to 26.00%, marking a decrease of 3.00%.
- For Other Income, as of Sep 2023, the value is ₹11.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹232.00 Cr. (Jun 2023) to ₹11.00 Cr., marking a decrease of ₹221.00 Cr..
- For Interest, as of Sep 2023, the value is ₹7.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from ₹8.00 Cr. (Jun 2023) to ₹7.00 Cr., marking a decrease of ₹1.00 Cr..
- For Depreciation, as of Sep 2023, the value is ₹26.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹24.00 Cr. (Jun 2023) to ₹26.00 Cr., marking an increase of ₹2.00 Cr..
- For Profit before tax, as of Sep 2023, the value is ₹191.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹497.00 Cr. (Jun 2023) to ₹191.00 Cr., marking a decrease of ₹306.00 Cr..
- For Tax %, as of Sep 2023, the value is 25.00%. The value appears to be increasing, which may not be favorable. It has increased from 14.00% (Jun 2023) to 25.00%, marking an increase of 11.00%.
- For Net Profit, as of Sep 2023, the value is ₹143.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹426.00 Cr. (Jun 2023) to ₹143.00 Cr., marking a decrease of ₹283.00 Cr..
- For EPS in Rs, as of Sep 2023, the value is ₹14.94. The value appears to be declining and may need further review. It has decreased from ₹44.60 (Jun 2023) to ₹14.94, marking a decrease of ₹29.66.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: Unknown
Metric | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 1,958 | 2,254 | 2,201 | 2,356 | 2,531 | 2,784 | 2,919 | 3,341 | 3,305 | 2,491 | 3,052 | 4,545 | 4,043 |
Expenses | 1,602 | 1,847 | 1,767 | 1,828 | 1,901 | 2,103 | 2,313 | 2,582 | 2,576 | 1,886 | 2,322 | 3,048 | 2,817 |
Operating Profit | 356 | 407 | 434 | 528 | 629 | 681 | 607 | 759 | 729 | 605 | 730 | 1,497 | 1,226 |
OPM % | 18% | 18% | 20% | 22% | 25% | 24% | 21% | 23% | 22% | 24% | 24% | 33% | 30% |
Other Income | 9 | -50 | -26 | -15 | -3 | 37 | 38 | 16 | 16 | 18 | 211 | 124 | 245 |
Interest | 213 | 179 | 183 | 171 | 165 | 137 | 127 | 127 | 120 | 74 | 51 | 39 | 35 |
Depreciation | 106 | 82 | 82 | 85 | 82 | 86 | 110 | 117 | 131 | 111 | 87 | 94 | 99 |
Profit before tax | 46 | 96 | 143 | 257 | 380 | 495 | 407 | 531 | 495 | 437 | 802 | 1,489 | 1,337 |
Tax % | 3% | 26% | 24% | 29% | 32% | 23% | 13% | 34% | 20% | 25% | 19% | 23% | |
Net Profit | 44 | 71 | 109 | 182 | 258 | 380 | 356 | 351 | 397 | 326 | 650 | 1,142 | 1,048 |
EPS in Rs | 4.45 | 7.14 | 10.85 | 18.19 | 25.78 | 38.04 | 36.59 | 35.77 | 41.75 | 34.33 | 68.14 | 119.41 | 109.62 |
Dividend Payout % | 45% | 28% | 18% | 12% | 0% | 13% | 14% | 14% | 7% | 16% | 22% | 15% |
YoY Net Profit Growth
Year | 2012-2013 | 2013-2014 | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
YoY Net Profit Growth (%) | 61.36% | 53.52% | 66.97% | 41.76% | 47.29% | -6.32% | -1.40% | 13.11% | -17.88% | 99.39% | 75.69% |
Change in YoY Net Profit Growth (%) | 0.00% | -7.84% | 13.45% | -25.21% | 5.53% | -53.60% | 4.91% | 14.51% | -30.99% | 117.27% | -23.69% |
GHCL Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2012-2013 to 2022-2023.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | 5% |
5 Years: | 1% |
3 Years: | 11% |
TTM: | -14% |
Compounded Profit Growth | |
---|---|
10 Years: | 16% |
5 Years: | 11% |
3 Years: | 22% |
TTM: | -18% |
Stock Price CAGR | |
---|---|
10 Years: | 24% |
5 Years: | 29% |
3 Years: | 14% |
1 Year: | 15% |
Return on Equity | |
---|---|
10 Years: | 23% |
5 Years: | 22% |
3 Years: | 24% |
Last Year: | 17% |
Last Updated: Unknown
Balance Sheet
Last Updated: November 14, 2024, 11:41 pm
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 100 | 100 | 100 | 100 | 99 | 97 | 98 | 95 | 95 | 95 | 96 | 96 | 96 |
Reserves | 467 | 487 | 670 | 936 | 1,247 | 1,513 | 1,827 | 2,054 | 2,389 | 2,852 | 3,860 | 2,883 | 3,078 |
Borrowings | 1,558 | 1,486 | 1,324 | 1,365 | 1,463 | 1,322 | 1,302 | 1,254 | 782 | 788 | 361 | 210 | 175 |
Other Liabilities | 755 | 941 | 758 | 548 | 694 | 695 | 767 | 766 | 712 | 1,261 | 816 | 581 | 544 |
Total Liabilities | 2,880 | 3,014 | 2,851 | 2,949 | 3,504 | 3,628 | 3,995 | 4,169 | 3,978 | 4,995 | 5,133 | 3,770 | 3,893 |
Fixed Assets | 1,875 | 1,869 | 1,934 | 2,049 | 2,410 | 2,502 | 2,591 | 2,664 | 2,675 | 2,474 | 1,731 | 1,842 | 1,867 |
CWIP | 32 | 12 | 7 | 37 | 26 | 74 | 117 | 122 | 81 | 213 | 109 | 55 | 105 |
Investments | 5 | 7 | 2 | 15 | 9 | 10 | 12 | 9 | 15 | 17 | 380 | 420 | 572 |
Other Assets | 967 | 1,125 | 909 | 848 | 1,059 | 1,043 | 1,275 | 1,375 | 1,207 | 2,292 | 2,914 | 1,453 | 1,349 |
Total Assets | 2,880 | 3,014 | 2,851 | 2,949 | 3,504 | 3,628 | 3,995 | 4,169 | 3,978 | 4,995 | 5,133 | 3,770 | 3,893 |
Below is a detailed analysis of the balance sheet data for GHCL Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2024, the value is ₹96.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹96.00 Cr..
- For Reserves, as of Sep 2024, the value is ₹3,078.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹2,883.00 Cr. (Mar 2024) to ₹3,078.00 Cr., marking an increase of ₹195.00 Cr..
- For Borrowings, as of Sep 2024, the value is ₹175.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from ₹210.00 Cr. (Mar 2024) to ₹175.00 Cr., marking a decrease of ₹35.00 Cr..
- For Other Liabilities, as of Sep 2024, the value is ₹544.00 Cr.. The value appears to be improving (decreasing). It has decreased from ₹581.00 Cr. (Mar 2024) to ₹544.00 Cr., marking a decrease of ₹37.00 Cr..
- For Total Liabilities, as of Sep 2024, the value is ₹3,893.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹3,770.00 Cr. (Mar 2024) to ₹3,893.00 Cr., marking an increase of ₹123.00 Cr..
- For Fixed Assets, as of Sep 2024, the value is ₹1,867.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹1,842.00 Cr. (Mar 2024) to ₹1,867.00 Cr., marking an increase of ₹25.00 Cr..
- For CWIP, as of Sep 2024, the value is ₹105.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹55.00 Cr. (Mar 2024) to ₹105.00 Cr., marking an increase of ₹50.00 Cr..
- For Investments, as of Sep 2024, the value is ₹572.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹420.00 Cr. (Mar 2024) to ₹572.00 Cr., marking an increase of ₹152.00 Cr..
- For Other Assets, as of Sep 2024, the value is ₹1,349.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹1,453.00 Cr. (Mar 2024) to ₹1,349.00 Cr., marking a decrease of ₹104.00 Cr..
- For Total Assets, as of Sep 2024, the value is ₹3,893.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹3,770.00 Cr. (Mar 2024) to ₹3,893.00 Cr., marking an increase of ₹123.00 Cr..
Notably, the Reserves (₹3,078.00 Cr.) exceed the Borrowings (₹175.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
Month | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | 356.00 | 406.00 | 433.00 | 527.00 | 628.00 | 680.00 | 606.00 | 758.00 | 728.00 | -177.00 | -58.00 | -360.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 46 | 63 | 38 | 26 | 36 | 29 | 32 | 30 | 33 | 27 | 18 | 19 |
Inventory Days | 160 | 227 | 193 | 194 | 187 | 182 | 199 | 198 | 245 | 294 | 177 | 185 |
Days Payable | 175 | 233 | 155 | 110 | 107 | 109 | 106 | 102 | 121 | 107 | 53 | 63 |
Cash Conversion Cycle | 32 | 57 | 76 | 110 | 117 | 101 | 125 | 126 | 158 | 214 | 142 | 141 |
Working Capital Days | 40 | 32 | 31 | 23 | 42 | 39 | 55 | 56 | 91 | 128 | 58 | 58 |
ROCE % | 15% | 17% | 22% | 25% | 24% | 19% | 21% | 19% | 16% | 19% | 36% | 21% |
Mutual Fund Holdings
Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
---|---|---|---|---|---|---|
DSP Small Cap Fund | 3,115,010 | 1.53 | 181.08 | 3,115,010 | 2025-02-25 | 0% |
DSP Tax Saver Fund | 1,640,416 | 0.82 | 95.36 | 3,115,010 | 2025-02-25 | -47.34% |
Franklin India Smaller Companies Fund | 1,499,472 | 0.9 | 87.16 | 3,115,010 | 2025-02-25 | -51.86% |
UTI Aggressive Hybrid Fund | 541,859 | 0.66 | 31.5 | 3,115,010 | 2025-02-25 | -82.6% |
UTI Large & Mid Cap Fund | 228,863 | 0.67 | 13.3 | 3,115,010 | 2025-02-25 | -92.65% |
UTI Retirement Fund | 206,707 | 0.3 | 12.02 | 3,115,010 | 2025-02-25 | -93.36% |
Motilal Oswal Nifty Microcap 250 Index Fund | 74,886 | 0.94 | 4.35 | 3,115,010 | 2025-02-25 | -97.6% |
Groww Nifty Total Market Index Fund | 172 | 0.03 | 0.01 | 3,115,010 | 2025-02-25 | -99.99% |
Key Financial Ratios
Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
---|---|---|---|---|---|
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Basic EPS (Rs.) | 83.43 | 120.06 | 67.89 | 34.32 | 40.50 |
Diluted EPS (Rs.) | 83.33 | 120.06 | 67.89 | 34.23 | 40.50 |
Cash EPS (Rs.) | 93.61 | 129.28 | 80.36 | 48.37 | 55.56 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 311.17 | 413.83 | 324.73 | 261.47 | 226.18 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 311.17 | 413.83 | 324.73 | 261.47 | 226.18 |
Revenue From Operations / Share (Rs.) | 360.06 | 475.51 | 397.68 | 305.24 | 347.87 |
PBDIT / Share (Rs.) | 94.00 | 159.03 | 104.32 | 69.80 | 78.47 |
PBIT / Share (Rs.) | 83.33 | 149.17 | 92.03 | 55.76 | 64.67 |
PBT / Share (Rs.) | 103.58 | 153.05 | 85.34 | 46.16 | 52.06 |
Net Profit / Share (Rs.) | 82.94 | 119.42 | 68.07 | 34.32 | 41.74 |
NP After MI And SOA / Share (Rs.) | 82.94 | 119.42 | 68.07 | 34.32 | 41.74 |
PBDIT Margin (%) | 26.10 | 33.44 | 26.23 | 22.86 | 22.55 |
PBIT Margin (%) | 23.14 | 31.37 | 23.14 | 18.26 | 18.58 |
PBT Margin (%) | 28.76 | 32.18 | 21.45 | 15.12 | 14.96 |
Net Profit Margin (%) | 23.03 | 25.11 | 17.11 | 11.24 | 12.00 |
NP After MI And SOA Margin (%) | 23.03 | 25.11 | 17.11 | 11.24 | 12.00 |
Return on Networth / Equity (%) | 26.65 | 28.85 | 20.96 | 13.12 | 18.45 |
Return on Capital Employeed (%) | 23.76 | 31.97 | 22.97 | 15.93 | 19.01 |
Return On Assets (%) | 21.06 | 22.23 | 12.94 | 8.19 | 9.51 |
Long Term Debt / Equity (X) | 0.03 | 0.06 | 0.13 | 0.22 | 0.37 |
Total Debt / Equity (X) | 0.06 | 0.08 | 0.24 | 0.24 | 0.50 |
Asset Turnover Ratio (%) | 0.77 | 0.89 | 0.84 | 0.69 | 0.79 |
Current Ratio (X) | 4.30 | 4.69 | 1.82 | 1.71 | 1.37 |
Quick Ratio (X) | 2.73 | 3.54 | 1.03 | 0.53 | 0.52 |
Inventory Turnover Ratio (X) | 1.55 | 1.49 | 1.75 | 1.48 | 1.68 |
Dividend Payout Ratio (NP) (%) | 20.96 | 12.49 | 8.08 | 0.00 | 19.54 |
Dividend Payout Ratio (CP) (%) | 18.57 | 11.54 | 6.84 | 0.00 | 14.68 |
Earning Retention Ratio (%) | 79.04 | 87.51 | 91.92 | 0.00 | 80.46 |
Cash Earning Retention Ratio (%) | 81.43 | 88.46 | 93.16 | 0.00 | 85.32 |
Interest Coverage Ratio (X) | 35.33 | 39.31 | 15.59 | 7.27 | 6.22 |
Interest Coverage Ratio (Post Tax) (X) | 23.56 | 27.90 | 10.41 | 4.58 | 4.31 |
Enterprise Value (Cr.) | 3948.48 | 5021.66 | 5717.82 | 2744.15 | 1812.81 |
EV / Net Operating Revenue (X) | 1.15 | 1.10 | 1.51 | 0.94 | 0.54 |
EV / EBITDA (X) | 4.39 | 3.30 | 5.77 | 4.14 | 2.43 |
MarketCap / Net Operating Revenue (X) | 1.23 | 1.06 | 1.38 | 0.75 | 0.25 |
Retention Ratios (%) | 79.03 | 87.50 | 91.91 | 0.00 | 80.45 |
Price / BV (X) | 1.42 | 1.22 | 1.69 | 0.88 | 0.39 |
Price / Net Operating Revenue (X) | 1.23 | 1.06 | 1.38 | 0.75 | 0.25 |
EarningsYield | 0.18 | 0.23 | 0.12 | 0.14 | 0.47 |
After reviewing the key financial ratios for GHCL Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 83.43. This value is within the healthy range. It has decreased from 120.06 (Mar 23) to 83.43, marking a decrease of 36.63.
- For Diluted EPS (Rs.), as of Mar 24, the value is 83.33. This value is within the healthy range. It has decreased from 120.06 (Mar 23) to 83.33, marking a decrease of 36.73.
- For Cash EPS (Rs.), as of Mar 24, the value is 93.61. This value is within the healthy range. It has decreased from 129.28 (Mar 23) to 93.61, marking a decrease of 35.67.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 311.17. It has decreased from 413.83 (Mar 23) to 311.17, marking a decrease of 102.66.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 311.17. It has decreased from 413.83 (Mar 23) to 311.17, marking a decrease of 102.66.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 360.06. It has decreased from 475.51 (Mar 23) to 360.06, marking a decrease of 115.45.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 94.00. This value is within the healthy range. It has decreased from 159.03 (Mar 23) to 94.00, marking a decrease of 65.03.
- For PBIT / Share (Rs.), as of Mar 24, the value is 83.33. This value is within the healthy range. It has decreased from 149.17 (Mar 23) to 83.33, marking a decrease of 65.84.
- For PBT / Share (Rs.), as of Mar 24, the value is 103.58. This value is within the healthy range. It has decreased from 153.05 (Mar 23) to 103.58, marking a decrease of 49.47.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 82.94. This value is within the healthy range. It has decreased from 119.42 (Mar 23) to 82.94, marking a decrease of 36.48.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 82.94. This value is within the healthy range. It has decreased from 119.42 (Mar 23) to 82.94, marking a decrease of 36.48.
- For PBDIT Margin (%), as of Mar 24, the value is 26.10. This value is within the healthy range. It has decreased from 33.44 (Mar 23) to 26.10, marking a decrease of 7.34.
- For PBIT Margin (%), as of Mar 24, the value is 23.14. This value exceeds the healthy maximum of 20. It has decreased from 31.37 (Mar 23) to 23.14, marking a decrease of 8.23.
- For PBT Margin (%), as of Mar 24, the value is 28.76. This value is within the healthy range. It has decreased from 32.18 (Mar 23) to 28.76, marking a decrease of 3.42.
- For Net Profit Margin (%), as of Mar 24, the value is 23.03. This value exceeds the healthy maximum of 10. It has decreased from 25.11 (Mar 23) to 23.03, marking a decrease of 2.08.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is 23.03. This value exceeds the healthy maximum of 20. It has decreased from 25.11 (Mar 23) to 23.03, marking a decrease of 2.08.
- For Return on Networth / Equity (%), as of Mar 24, the value is 26.65. This value is within the healthy range. It has decreased from 28.85 (Mar 23) to 26.65, marking a decrease of 2.20.
- For Return on Capital Employeed (%), as of Mar 24, the value is 23.76. This value is within the healthy range. It has decreased from 31.97 (Mar 23) to 23.76, marking a decrease of 8.21.
- For Return On Assets (%), as of Mar 24, the value is 21.06. This value is within the healthy range. It has decreased from 22.23 (Mar 23) to 21.06, marking a decrease of 1.17.
- For Long Term Debt / Equity (X), as of Mar 24, the value is 0.03. This value is below the healthy minimum of 0.2. It has decreased from 0.06 (Mar 23) to 0.03, marking a decrease of 0.03.
- For Total Debt / Equity (X), as of Mar 24, the value is 0.06. This value is within the healthy range. It has decreased from 0.08 (Mar 23) to 0.06, marking a decrease of 0.02.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 0.77. It has decreased from 0.89 (Mar 23) to 0.77, marking a decrease of 0.12.
- For Current Ratio (X), as of Mar 24, the value is 4.30. This value exceeds the healthy maximum of 3. It has decreased from 4.69 (Mar 23) to 4.30, marking a decrease of 0.39.
- For Quick Ratio (X), as of Mar 24, the value is 2.73. This value exceeds the healthy maximum of 2. It has decreased from 3.54 (Mar 23) to 2.73, marking a decrease of 0.81.
- For Inventory Turnover Ratio (X), as of Mar 24, the value is 1.55. This value is below the healthy minimum of 4. It has increased from 1.49 (Mar 23) to 1.55, marking an increase of 0.06.
- For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 20.96. This value is within the healthy range. It has increased from 12.49 (Mar 23) to 20.96, marking an increase of 8.47.
- For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 18.57. This value is below the healthy minimum of 20. It has increased from 11.54 (Mar 23) to 18.57, marking an increase of 7.03.
- For Earning Retention Ratio (%), as of Mar 24, the value is 79.04. This value exceeds the healthy maximum of 70. It has decreased from 87.51 (Mar 23) to 79.04, marking a decrease of 8.47.
- For Cash Earning Retention Ratio (%), as of Mar 24, the value is 81.43. This value exceeds the healthy maximum of 70. It has decreased from 88.46 (Mar 23) to 81.43, marking a decrease of 7.03.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 35.33. This value is within the healthy range. It has decreased from 39.31 (Mar 23) to 35.33, marking a decrease of 3.98.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 23.56. This value is within the healthy range. It has decreased from 27.90 (Mar 23) to 23.56, marking a decrease of 4.34.
- For Enterprise Value (Cr.), as of Mar 24, the value is 3,948.48. It has decreased from 5,021.66 (Mar 23) to 3,948.48, marking a decrease of 1,073.18.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.15. This value is within the healthy range. It has increased from 1.10 (Mar 23) to 1.15, marking an increase of 0.05.
- For EV / EBITDA (X), as of Mar 24, the value is 4.39. This value is below the healthy minimum of 5. It has increased from 3.30 (Mar 23) to 4.39, marking an increase of 1.09.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.23. This value is within the healthy range. It has increased from 1.06 (Mar 23) to 1.23, marking an increase of 0.17.
- For Retention Ratios (%), as of Mar 24, the value is 79.03. This value exceeds the healthy maximum of 70. It has decreased from 87.50 (Mar 23) to 79.03, marking a decrease of 8.47.
- For Price / BV (X), as of Mar 24, the value is 1.42. This value is within the healthy range. It has increased from 1.22 (Mar 23) to 1.42, marking an increase of 0.20.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.23. This value is within the healthy range. It has increased from 1.06 (Mar 23) to 1.23, marking an increase of 0.17.
- For EarningsYield, as of Mar 24, the value is 0.18. This value is below the healthy minimum of 5. It has decreased from 0.23 (Mar 23) to 0.18, marking a decrease of 0.05.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Strength | Weakness |
---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in GHCL Ltd:
- Net Profit Margin: 23.03%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 23.76% (Industry Average ROCE: 9.52%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 26.65% (Industry Average ROE: 6.89%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 23.56
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.73
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 9.31 (Industry average Stock P/E: 42.25)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.06
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 23.03%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Chemicals - Inorganic - Caustic Soda/Soda Ash | GHCL House, Opp. Punjabi Hall, Ahmedabad Gujarat 380009 | ghclinfo@ghcl.co.in http://www.ghcl.co.in |
Management | |
---|---|
Name | Position Held |
Mr. Anurag Dalmia | Non Executive Chairman |
Mr. R S Jalan | Managing Director |
Mr. Raman Chopra | Executive Director (Finance) & CFO |
Mr. Neelabh Dalmia | Executive Director |
Justice(Retd) Ravindra Singh | Independent Director |
Mr. Arun Kumar Jain | Independent Director |
Dr. Manoj Vaish | Independent Director |
Mrs. Vijaylaxmi Joshi | Independent Director |
FAQ
What is the latest intrinsic value of GHCL Ltd?
Let's break down GHCL Ltd's intrinsic value simply:
We calculate intrinsic value using the PE Ratio Method - comparing the company's current price-to-earnings ratio with its historical average and industry peers. Think of it like checking if a stock is "on sale" compared to its typical pricing.
As of 27 February 2025:
- Calculated Fair Value: ₹435.20
- Current Market Price: ₹584.00
- Variance: 25.48% lower
This suggests GHCL Ltd is currently overvalued by 25.48%. For context:
- Market Cap: 5,587 Cr.
- 52-Week Range: 779/435
- Reserves (Sep 2024): 3,078 Cr
- Liabilities: 3,893 Cr
Remember: The PE method gives a snapshot based on earnings multiples. While useful for quick comparisons, investors should also consider growth prospects, industry trends, and economic conditions. This calculation assumes historical PE ratios remain relevant - always verify with current market dynamics.
What is the Market Cap of GHCL Ltd?
The Market Cap of GHCL Ltd is 5,587 Cr..
What is the current Stock Price of GHCL Ltd as on 27 February 2025?
The current stock price of GHCL Ltd as on 27 February 2025 is ₹584.
What is the High / Low of GHCL Ltd stocks in FY 2024-2025?
In FY 2024-2025, the High / Low of GHCL Ltd stocks is 779/435.
What is the Stock P/E of GHCL Ltd?
The Stock P/E of GHCL Ltd is 9.31.
What is the Book Value of GHCL Ltd?
The Book Value of GHCL Ltd is 331.
What is the Dividend Yield of GHCL Ltd?
The Dividend Yield of GHCL Ltd is 2.04 %.
What is the ROCE of GHCL Ltd?
The ROCE of GHCL Ltd is 20.6 %.
What is the ROE of GHCL Ltd?
The ROE of GHCL Ltd is 17.3 %.
What is the Face Value of GHCL Ltd?
The Face Value of GHCL Ltd is 10.0.